Literature DB >> 24711622

STAT3, STAT4, NFATc1, and CTCF regulate PD-1 through multiple novel regulatory regions in murine T cells.

James W Austin1, Peiyuan Lu, Parimal Majumder, Rafi Ahmed, Jeremy M Boss.   

Abstract

Programmed death-1 (PD-1) is a crucial negative regulator of CD8 T cell development and function, yet the mechanisms that control its expression are not fully understood. Through a nonbiased DNase I hypersensitivity assay, four novel regulatory regions within the Pdcd1 locus were identified. Two of these elements flanked the locus, bound the transcriptional insulator protein CCCTC-binding factor, and interacted with each other, creating a potential regulatory compartmentalization of the locus. In response to T cell activation signaling, NFATc1 bound to two of the novel regions that function as independent regulatory elements. STAT binding sites were identified in these elements as well. In splenic CD8 T cells, TCR-induced PD-1 expression was augmented by IL-6 and IL-12, inducers of STAT3 and STAT4 activity, respectively. IL-6 or IL-12 on its own did not induce PD-1. Importantly, STAT3/4 and distinct chromatin modifications were associated with the novel regulatory regions following cytokine stimulation. The NFATc1/STAT regulatory regions were found to interact with the promoter region of the Pdcd1 gene, providing a mechanism for their action. Together these data add multiple novel distal regulatory regions and pathways to the control of PD-1 expression and provide a molecular mechanism by which proinflammatory cytokines, such as IL-6 or IL-12, can augment PD-1 expression.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24711622      PMCID: PMC4011967          DOI: 10.4049/jimmunol.1302750

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  68 in total

1.  The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands.

Authors:  Audrey L Kinter; Emily J Godbout; Jonathan P McNally; Irini Sereti; Gregg A Roby; Marie A O'Shea; Anthony S Fauci
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

2.  NFATc1 regulates PD-1 expression upon T cell activation.

Authors:  Kenneth J Oestreich; Hyesuk Yoon; Rafi Ahmed; Jeremy M Boss
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

Review 3.  Chromatin insulators: regulatory mechanisms and epigenetic inheritance.

Authors:  Ashley M Bushey; Elizabeth R Dorman; Victor G Corces
Journal:  Mol Cell       Date:  2008-10-10       Impact factor: 17.970

4.  ChIP-seq accurately predicts tissue-specific activity of enhancers.

Authors:  Axel Visel; Matthew J Blow; Zirong Li; Tao Zhang; Jennifer A Akiyama; Amy Holt; Ingrid Plajzer-Frick; Malak Shoukry; Crystal Wright; Feng Chen; Veena Afzal; Bing Ren; Edward M Rubin; Len A Pennacchio
Journal:  Nature       Date:  2009-02-12       Impact factor: 49.962

Review 5.  Cytokine signaling modules in inflammatory responses.

Authors:  John J O'Shea; Peter J Murray
Journal:  Immunity       Date:  2008-04       Impact factor: 31.745

6.  Interferon-sensitive response element (ISRE) is mainly responsible for IFN-alpha-induced upregulation of programmed death-1 (PD-1) in macrophages.

Authors:  Hae-Yun Cho; Soo-Woon Lee; Su-Kil Seo; Il-Whan Choi; Inhak Choi; Soo-Woong Lee
Journal:  Biochim Biophys Acta       Date:  2008-08-15

7.  Shadow enhancers as a source of evolutionary novelty.

Authors:  Joung-Woo Hong; David A Hendrix; Michael S Levine
Journal:  Science       Date:  2008-09-05       Impact factor: 47.728

8.  Interleukin-6/STAT3 signaling regulates the ability of naive T cells to acquire B-cell help capacities.

Authors:  Fouad Eddahri; Sébastien Denanglaire; Fabrice Bureau; Rosanne Spolski; Warren J Leonard; Oberdan Leo; Fabienne Andris
Journal:  Blood       Date:  2008-11-19       Impact factor: 22.113

9.  The insulator factor CTCF controls MHC class II gene expression and is required for the formation of long-distance chromatin interactions.

Authors:  Parimal Majumder; Jorge A Gomez; Brian P Chadwick; Jeremy M Boss
Journal:  J Exp Med       Date:  2008-03-17       Impact factor: 14.307

10.  Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade.

Authors:  Nobuhiro Nakamoto; Hyosun Cho; Abraham Shaked; Kim Olthoff; Mary E Valiga; Mary Kaminski; Emma Gostick; David A Price; Gordon J Freeman; E John Wherry; Kyong-Mi Chang
Journal:  PLoS Pathog       Date:  2009-02-27       Impact factor: 6.823

View more
  57 in total

1.  The Exportin-1 Inhibitor Selinexor Exerts Superior Antitumor Activity when Combined with T-Cell Checkpoint Inhibitors.

Authors:  Matthew R Farren; Rebecca C Hennessey; Reena Shakya; Omar Elnaggar; Gregory Young; Kari Kendra; Yosef Landesman; Sivan Elloul; Marsha Crochiere; Boris Klebanov; Trinayan Kashyap; Christin E Burd; Gregory B Lesinski
Journal:  Mol Cancer Ther       Date:  2017-02-01       Impact factor: 6.261

2.  A Thpok-Directed Transcriptional Circuitry Promotes Bcl6 and Maf Expression to Orchestrate T Follicular Helper Differentiation.

Authors:  Melanie S Vacchio; Thomas Ciucci; Yayi Gao; Masashi Watanabe; Mariah Balmaceno-Criss; Mitchell T McGinty; Allan Huang; Qi Xiao; Cameron McConkey; Yongmei Zhao; Jyoti Shetty; Bao Tran; Marion Pepper; Golnaz Vahedi; Marc K Jenkins; Dorian B McGavern; Rémy Bosselut
Journal:  Immunity       Date:  2019-08-15       Impact factor: 31.745

Review 3.  Targeting the IL-6/JAK/STAT3 signalling axis in cancer.

Authors:  Daniel E Johnson; Rachel A O'Keefe; Jennifer R Grandis
Journal:  Nat Rev Clin Oncol       Date:  2018-02-06       Impact factor: 66.675

4.  Unlocking the epigenetic code of T cell exhaustion.

Authors:  Jiazhu Wu; Huidong Shi
Journal:  Transl Cancer Res       Date:  2017-03       Impact factor: 1.241

Review 5.  Transcriptional and epigenetic regulation of PD-1 expression.

Authors:  Zengde Chi; Yan Lu; Yinlong Yang; Bingqing Li; Peiyuan Lu
Journal:  Cell Mol Life Sci       Date:  2021-03-18       Impact factor: 9.261

6.  NF-κB regulates PD-1 expression in macrophages.

Authors:  Alexander P R Bally; Peiyuan Lu; Yan Tang; James W Austin; Christopher D Scharer; Rafi Ahmed; Jeremy M Boss
Journal:  J Immunol       Date:  2015-03-25       Impact factor: 5.422

Review 7.  Pembrolizumab in the management of metastatic melanoma.

Authors:  Lavinia Spain; Eugenie Younger; Emine Hatipoglu; James Larkin
Journal:  Melanoma Manag       Date:  2015-11-12

8.  FUT4 is involved in PD-1-related immunosuppression and leads to worse survival in patients with operable lung adenocarcinoma.

Authors:  Chang Liu; Zhi Li; Shuo Wang; Yibo Fan; Simeng Zhang; Xianghong Yang; Kezuo Hou; Jianhua Tong; Xuejun Hu; Xiaonan Shi; Xiaoxun Wang; Yunpeng Liu; Xiaofang Che; Xiujuan Qu
Journal:  J Cancer Res Clin Oncol       Date:  2018-10-24       Impact factor: 4.553

Review 9.  Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family.

Authors:  Frank A Schildberg; Sarah R Klein; Gordon J Freeman; Arlene H Sharpe
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

Review 10.  The structure, expression, and multifaceted role of immune-checkpoint protein VISTA as a critical regulator of anti-tumor immunity, autoimmunity, and inflammation.

Authors:  Wenwen Xu; TạMinh Hiếu; Subramaniam Malarkannan; Li Wang
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.